Biotest Aktiengesellschaft (BIO.DE)
EUR 41.4
(0.49%)
EUR 41.4
(0.49%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 3.21 EUR | 501.25% |
| 2022 | -0.80 EUR | 50.0% |
| 2021 | -1.60 EUR | -102.53% |
| 2020 | -0.79 EUR | -558.33% |
| 2019 | -0.12 EUR | -102.61% |
| 2018 | 4.59 EUR | 5292.31% |
| 2017 | -0.09 EUR | 92.38% |
| 2016 | -1.16 EUR | 44.23% |
| 2015 | -2.08 EUR | -533.33% |
| 2014 | 0.48 EUR | -43.53% |
| 2013 | 0.85 EUR | -9.57% |
| 2012 | 0.94 EUR | -28.24% |
| 2011 | 1.31 EUR | 25.96% |
| 2010 | 1.04 EUR | 44.44% |
| 2009 | 0.72 EUR | 0.0% |
| 2008 | 0.72 EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| 2005 | - EUR | -100.0% |
| 2004 | 0.19 EUR | 173.08% |
| 2003 | -0.26 EUR | -130.59% |
| 2002 | 0.85 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.75 EUR | -23.47% |
| 2024 Q2 | 0.25 EUR | -66.67% |
| 2023 Q3 | 2.19 EUR | 291.07% |
| 2023 Q1 | -0.52 EUR | -922.78% |
| 2023 Q2 | 0.56 EUR | 207.69% |
| 2023 Q4 | 0.98 EUR | -55.25% |
| 2023 FY | - EUR | 501.25% |
| 2022 Q4 | 0.06 EUR | 117.08% |
| 2022 Q3 | -0.37 EUR | 5.13% |
| 2022 Q2 | -0.39 EUR | -200.0% |
| 2022 Q1 | -0.13 EUR | 88.39% |
| 2022 FY | - EUR | 50.0% |
| 2021 FY | - EUR | -102.53% |
| 2021 Q1 | -0.37 EUR | -3692.23% |
| 2021 Q2 | -0.11 EUR | 70.27% |
| 2021 Q3 | -0.26 EUR | -136.36% |
| 2021 Q4 | -1.12 EUR | -330.77% |
| 2020 FY | - EUR | -558.33% |
| 2020 Q1 | -0.28 EUR | -502.15% |
| 2020 Q2 | -0.16 EUR | 42.86% |
| 2020 Q3 | -0.39 EUR | -143.75% |
| 2020 Q4 | 0.01 EUR | 102.64% |
| 2019 Q1 | -0.04 EUR | 80.95% |
| 2019 Q3 | -0.13 EUR | -285.71% |
| 2019 Q4 | -0.05 EUR | 64.23% |
| 2019 FY | - EUR | -102.61% |
| 2019 Q2 | 0.07 EUR | 275.0% |
| 2018 Q2 | 4.01 EUR | 498.51% |
| 2018 FY | - EUR | 5292.31% |
| 2018 Q1 | 0.67 EUR | 39.58% |
| 2018 Q3 | 0.13 EUR | -96.76% |
| 2018 Q4 | -0.21 EUR | -261.54% |
| 2017 Q3 | -0.12 EUR | -180.0% |
| 2017 Q2 | 0.15 EUR | 124.19% |
| 2017 FY | - EUR | 92.38% |
| 2017 Q4 | 0.48 EUR | 500.0% |
| 2017 Q1 | -0.62 EUR | 45.61% |
| 2016 Q4 | -1.14 EUR | -395.65% |
| 2016 Q2 | 0.14 EUR | 180.0% |
| 2016 Q1 | 0.05 EUR | -64.29% |
| 2016 FY | - EUR | 44.23% |
| 2016 Q3 | -0.23 EUR | -264.29% |
| 2015 FY | - EUR | -533.33% |
| 2015 Q3 | -2.17 EUR | -2311.11% |
| 2015 Q4 | 0.14 EUR | 106.45% |
| 2015 Q2 | -0.09 EUR | -345.23% |
| 2015 Q1 | 0.04 EUR | 1511.54% |
| 2014 Q4 | -0.00 EUR | -101.86% |
| 2014 FY | - EUR | -43.53% |
| 2014 Q1 | 0.13 EUR | -38.1% |
| 2014 Q2 | 0.22 EUR | 69.23% |
| 2014 Q3 | 0.14 EUR | -36.36% |
| 2013 Q3 | 0.22 EUR | -8.33% |
| 2013 FY | - EUR | -9.57% |
| 2013 Q1 | 0.20 EUR | -56.52% |
| 2013 Q2 | 0.24 EUR | 20.0% |
| 2013 Q4 | 0.21 EUR | -4.55% |
| 2012 Q4 | 0.46 EUR | 187.5% |
| 2012 FY | - EUR | -28.24% |
| 2012 Q1 | 0.11 EUR | -45.0% |
| 2012 Q2 | 0.17 EUR | 54.55% |
| 2012 Q3 | 0.16 EUR | -5.88% |
| 2011 FY | - EUR | 25.96% |
| 2011 Q4 | 0.20 EUR | -74.03% |
| 2011 Q1 | 0.14 EUR | -36.36% |
| 2011 Q3 | 0.77 EUR | 305.26% |
| 2011 Q2 | 0.19 EUR | 35.71% |
| 2010 Q4 | 0.22 EUR | 1554.14% |
| 2010 Q3 | 0.01 EUR | -93.0% |
| 2010 Q2 | 0.19 EUR | -69.35% |
| 2010 FY | - EUR | 44.44% |
| 2010 Q1 | 0.62 EUR | 722.28% |
| 2009 Q4 | 0.08 EUR | -68.58% |
| 2009 FY | - EUR | 0.0% |
| 2009 Q2 | 0.22 EUR | 10.0% |
| 2009 Q1 | 0.20 EUR | 0.0% |
| 2009 Q3 | 0.24 EUR | 9.09% |
| 2008 FY | - EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| 2005 FY | - EUR | -100.0% |
| 2004 FY | - EUR | 173.08% |
| 2003 FY | - EUR | -130.59% |
| 2002 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| BioNTech SE | 3.87 EUR | 17.054% |
| CureVac N.V. | -1.18 EUR | 372.034% |
| Biotest Aktiengesellschaft | 3.21 EUR | 0.0% |
| BRAIN Biotech AG | -0.38 EUR | 944.737% |
| Formycon AG | 4.76 EUR | 32.563% |
| Heidelberg Pharma AG | -0.44 EUR | 829.545% |
| Medigene AG | -0.66 EUR | 586.364% |